ETCGX (ETCGX) Stock Price & Analysis
ETCGX (ETCGX) fell 1.75% to USD 50.06 as of June 10, 2026 at 21:38 UTC, according to Nexqual real-time market data.
ETCGX last closed at USD 50.95; the session ranged USD 50.06–50.06 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 40.73–53.4 (NAS). Source: Nexqual, June 10, 2026 at 21:38 UTC.
Key Statistics (as of June 10, 2026 at 21:38 UTC)
| Price | USD 50.06 |
|---|---|
| Change | ▼ 1.75% (down) |
| Previous Close | USD 50.95 |
| Open | USD 50.06 |
| Day Range | USD 50.06 – 50.06 |
| 52-Week Range | USD 40.73 – 53.4 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (ETCGX)
Nexqual's technical model rates ETCGX "STRONG BUY" based on 5 bullish and 0 bearish signals across 123 daily candles, as of June 10, 2026 at 21:38 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 59.88 (neutral) |
| vs SMA50 | Above (USD 47.57) |
| MACD | 1 (positive) |
Financial Health Score (ETCGX)
Nexqual rates ETCGX's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 21:38 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ETCHX | Eventide Healthcare & Life Scie | USD 41.67 | ▲ 0.41% |
| ETAGX | Eventide Gilead Fund Class A | USD 59.54 | ▼ 1.15% |
| ETILX | Eventide Gilead Fund Institutio | USD 62.72 | ▼ 1.15% |
| ETGLX | Eventide Gilead Fund | USD 60.1 | ▼ 1.14% |
| ETAHX | Eventide Healthcare & Life Scie | USD 46.39 | ▲ 0.41% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 21:38 UTC. This page is informational and not investment advice.